Internal Medicine
WHO: More than 100 reasons to quit tobacco.
14 Jun, 2021 | 08:38h | UTCMore than 100 reasons to quit tobacco – World Health Organization
Commentary on Twitter (thread – click for more)
Quitting tobacco 🚭 can be challenging but there are more than 💯 reasons to #CommitToQuit & start living a healthier life.
Find out more 👉https://t.co/8uBEMvH0cu pic.twitter.com/iwrt86xSVo
— World Health Organization (WHO) (@WHO) June 13, 2021
High COVID vaccine uptake may protect the unvaccinated.
11 Jun, 2021 | 08:34h | UTCHigh COVID vaccine uptake may protect the unvaccinated – CIDRAP
Original Study: Community-level evidence for SARS-CoV-2 vaccine protection of unvaccinated individuals – Nature Medicine
Commentaries on Twitter
Just published @NatureMedicine
Evidence that "vaccination not only protects individuals who have been vaccinated but also provides cross-protection to unvaccinated individuals in the community" as seen in kids benefiting from high % of adults vaxxedhttps://t.co/IPQo6WTFZX pic.twitter.com/jtfD93onnn— Eric Topol (@EricTopol) June 10, 2021
https://twitter.com/niklasf/status/1402950991268433923
Opinion | The Covid-19 Delta variant poses a threat to our return to ‘normal’.
11 Jun, 2021 | 08:23h | UTCThe Covid-19 Delta variant poses a threat to our return to ‘normal’ – CNN
Commentary on Twitter
https://twitter.com/HoltgraveHealth/status/1402948596476039171
RCT: In patients with atrial fibrillation or mechanical heart valves treated with warfarin undergoing surgery, postoperative bridging treatment with low molecular weight heparin did not prevent major thromboembolism.
11 Jun, 2021 | 08:19h | UTC
Commentary on Twitter
P-E-R-S-E-V-E-R-A-N-C-E = 15 yrs from start to BMJ publication. Bottom line: in pts with atrial fibrillation or mechanical heart valves who had warfarin interrupted for a procedure, we found no benefit of
postop LMWH bridging to prevent major
thromboembolism @canvector @CIHR_ICRH https://t.co/9z0XTQgsbA— Professor Susan R Kahn (@SusanRKahn1) June 10, 2021
WHO Report: Global antimicrobial resistance and use surveillance system.
11 Jun, 2021 | 08:22h | UTCNews Release: Record response to WHO’s call for antimicrobial resistance surveillance reports in 2020 – World Health Organization
Commentary: WHO reveals new global antibiotic resistance data, more concerns – CIDRAP
Commentary on Twitter (thread – click for more)
WHO received over 3⃣ million reports for the Global #AntimicrobialResistance and Use Surveillance System (GLASS)
The more information we have the better placed the 🌏
is to tackle this increasingly serious health threat.👉 https://t.co/ccZCzdyZUc
pic.twitter.com/DMuLwVu4rC— World Health Organization (WHO) (@WHO) June 9, 2021
M-A: Safety of thoracentesis and tube thoracostomy in patients with uncorrected coagulopathy.
11 Jun, 2021 | 08:15h | UTCCommentary: Is Thoracentesis Safe in Coagulopathic Patients? – JournalFeed
Antiarrhythmic drugs for atrial fibrillation in the outpatient setting: common clinical scenarios and pearls for the primary care clinician.
11 Jun, 2021 | 08:16h | UTC
The furosemide stress test: current use and future potential.
11 Jun, 2021 | 08:12h | UTCThe furosemide stress test: current use and future potential – Renal Failure
Editorial: Embrace the WHO’s new naming system for coronavirus variants.
10 Jun, 2021 | 09:48h | UTCEmbrace the WHO’s new naming system for coronavirus variants – Nature
Case series: Adjunct immune globulin for vaccine-induced thrombotic thrombocytopenia.
10 Jun, 2021 | 09:46h | UTC
Cohort study: the use of potentially inappropriate medications in adults with chronic kidney disease is common and linked to increased risk of hospitalization, mortality, and falls.
11 Jun, 2021 | 08:11h | UTCRisk of Potentially Inappropriate Medications in Adults With CKD: Findings From the Chronic Renal Insufficiency Cohort (CRIC) Study – American Journal of Kidney Diseases (link to abstract – $ for full-text)
Commentary on Twitter
Risk of Potentially Inappropriate Medications in Adults With CKD: Findings From @CRICStudyhttps://t.co/1NgaqcJF5g@Rasheeda_HallMD @cjdiamantidis @sankarnava @finkjc @UMmedschool @DukeKidney #CKD #VisualAbstract pic.twitter.com/PLouT1SL9d
— AJKD (@AJKDonline) June 2, 2021
Perspective | The four most urgent questions about long COVID.
10 Jun, 2021 | 09:47h | UTCThe four most urgent questions about long COVID – Nature
Perspective | Identifying and tracking SARS-CoV-2 variants — a challenge and an opportunity.
10 Jun, 2021 | 09:43h | UTC
COVID nails: these changes to your fingernails may show you’ve had coronavirus.
10 Jun, 2021 | 09:42h | UTCCOVID nails: these changes to your fingernails may show you’ve had coronavirus – The Conversation
Cluster-randomized trial: Wolbachia-infected Aedes aegypti (less susceptible than wild-type A. aegypti to dengue virus infection) deployments reduced the incidence of symptomatic dengue and resulted in fewer hospitalizations.
10 Jun, 2021 | 09:40h | UTCCommentary: ‘Miraculous’ mosquito hack cuts dengue by 77% – BBC
Video Abstract: Efficacy of Wolbachia-infected Mosquito Deployments for the Control of Dengue
2021 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis.
10 Jun, 2021 | 09:37h | UTCCommentary: The 2021 Treatment Guidelines for Rheumatoid Arthritis – Rheumatology Network
Infographic | Benefits and harms of exercise therapy in people with multimorbidity.
10 Jun, 2021 | 09:32h | UTC
Commentary on Twitter
Infographic. Benefits and harms of exercise therapy in people with multimorbidity
👀👀👇👇🔓https://t.co/eh3LvrOumY pic.twitter.com/vJDtIZ0txu
— Physio Meets Science (@PhysioMeScience) June 9, 2021
M-A: Effectiveness of telerehabilitation in physical therapist practice.
10 Jun, 2021 | 09:29h | UTC
[Preprint] RECOVERY trial finds aspirin does not improve survival for patients hospitalized with COVID-19.
9 Jun, 2021 | 08:28h | UTCNews Release: RECOVERY trial finds aspirin does not improve survival for patients hospitalised with COVID-19 – University of Oxford
Original Study: Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial – medRxiv
Commentary on Twitter (thread – click for more)
RECOVERY Pre-print: Aspirin
14,892 patients randomised to aspirin vs. usual care
– no impact on all-cause mortality (17% vs. 17%)
– similar results in all pre-specified subgroupshttps://t.co/ay5Xg4GBVD pic.twitter.com/aNJ09RTTOa— Martin Landray (@MartinLandray) June 8, 2021
COVID-19 Imaging: What we know now and what remains unknown.
9 Jun, 2021 | 08:27h | UTCCOVID-19 Imaging: What We Know Now and What Remains Unknown – Radiology
Systematic review: Frequency, signs and symptoms, and criteria adopted for long COVID-19.
9 Jun, 2021 | 08:22h | UTC
M-A: Hospital-at-home interventions for patients with chronic disease who present to the emergency department – similar mortality risk, lower risk for readmission, lower depression and anxiety scores, and a lower risk for long-term care admission vs. in-hospital stay.
9 Jun, 2021 | 08:20h | UTCInvited commentary: Hospitalization at Home for Patients With Acute Exacerbation of Chronic Disease—Further Evidence to Inform Practice – JAMA Network Open
Related: Pandemic Boosts an Old Idea—Bringing Acute Care to the Patient AND Randomized trial: Admission Avoidance Hospital at Home + Geriatric Assessment led to similar outcomes compared to hospital admission for older persons AND Most COVID-19 patients receiving home-based hospital care did not require escalation to traditional hospital setting – Approximately 1 in 5 were admitted within 14 days. Higher oxygen saturation was associated with decreased odds of transfer, whereas higher comorbidity burden was associated with increased risk.
Summary | WHO recommendations on the treatment of drug-resistant tuberculosis, 2020 update.
9 Jun, 2021 | 08:12h | UTCOriginal Guideline: WHO Consolidated Guidelines on Tuberculosis, Module 4: Treatment – Drug-Resistant Tuberculosis Treatment
Commentary on Twitter
🆕💥💥@ERSpublications
WHO guidelines on the treatment of drug-resistant TB contain the latest recommendations on shorter or longer all oral treatment regimens for patients with drug-resistant TB, including the medicines to be used& supportive measures https://t.co/qeeftVYdYN pic.twitter.com/4NKNNjz3Gh— Antibiotic Steward Bassam Ghanem 🅱️C🆔🅿️🌟 (@ABsteward) June 8, 2021
No health issues in babies whose moms got flu vaccine while pregnant.
9 Jun, 2021 | 08:17h | UTCNo health issues in babies whose moms got flu vaccine while pregnant – CIDRAP
Original study: Association of Maternal Influenza Vaccination During Pregnancy With Early Childhood Health Outcomes – JAMA (free for a limited period)
Editorial: Realizing the Potential of Maternal Influenza Vaccination (free for a limited period)
Commentary on Twitter
https://twitter.com/ericbenchimol/status/1402307635240706048
FDA approvement of Alzheimer’s drug sparks controversy among doctors.
9 Jun, 2021 | 08:18h | UTCNews release: FDA Grants Accelerated Approval for Alzheimer’s Drug – U.S. Food & Drug Administration
Commentaries: ICER Issues Statement on the FDA’s Approval of Aducanumab for Alzheimer’s Disease – Institute for Clinical and Economic Review AND Landmark Alzheimer’s Drug Approval Confounds Research Community – Nature AND FDA approves Alzheimer’s drug from Biogen, against experts’ advice – NBC News AND F.D.A. Approves Alzheimer’s Drug Despite Fierce Debate Over Whether It Works – The New York Times (a few articles per month are free) AND Alzheimer’s drug approved despite doubts about effectiveness – Science (a few articles per month are free) AND The FDA Has Approved A New Alzheimer’s Drug — Here’s Why That’s Controversial – NPR AND Opinion: Bad medicine: aducanumab is a lackluster drug with a high price tag – STAT